AI assistant
Genpact LTD — Director's Dealing 2024
Nov 14, 2024
30790_dirs_2024-11-14_0a6ca20b-9728-44ea-a932-e7798daf1cb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Genpact LTD (G)
CIK: 0001398659
Period of Report: 2024-11-12
Reporting Person: Mehta Piyush (Senior Vice President and CHRO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-12 | Common Shares | M | 70000 | $27.65 | Acquired | 233049 | Direct |
| 2024-11-12 | Common Shares | S | 70000 | $46.4594 | Disposed | 163049 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | Employee Stock Option (Right to Buy) | $27.65 | M | 70000 | Disposed | 2026-03-31 | Common Shares (70000) | Direct |
Footnotes
F1: Includes 347 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 15, 2024. The reporting person currently holds a total of 9,689 shares under the ESPP.
F2: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.22 to $46.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.